Paracentesis for malignant ascites is usually performed as an in-patient procedure, with a median length of stay (LoS) of 3–5 days, with intermittent clamping of the drain due to a perceived risk of ...

Paracentesis is the standard treatment for refractory ascites in patients with cirrhosis, but it cannot prevent the recurrence of ascites. The placement of a transjugular intrahepatic portosystemic ...

Please provide your email address to receive an email when new articles are posted on . HONOLULU — Researchers found that patients with spontaneous bacterial peritonitis who underwent repeat ...

Please provide your email address to receive an email when new articles are posted on . A new low-flow ascites pump significantly reduced paracentesis frequency in patients with a contraindication to ...

HealthDay News— Aflibercept, a potent inhibitor of vascular endothelial growth factor (VEGF), shows clinical activity and increases the time to repeat paracentesis for patients with advanced ...

Aug. 23, 2004 — Large-volume paracentesis performed by gastrointestinal endoscopy assistants in an outpatient setting is safe and efficient, even in patients with marked thrombocytopenia or prolonged ...

Static ultrasound guidance is used to select and mark the site of needle insertion immediately before the procedure takes place. Dynamic ultrasound guidance, in contrast, is used to directly visualize ...

SANTA MONICA, CA / ACCESSWIRE / October 22, 2019 / BioVie Inc. (OTCQB:BIVI) ("BioVie" or the "Company"), a clinical-stage company developing innovative drug therapies for liver disease, announced ...

HERNIA is known to be more frequent among patients with cirrhosis of the liver, especially with ascites, than among those without liver disease. Chapman et al. 1 reported a rate of 10 per cent in 58 ...

Ghent, Belgium – 28 December 2023 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of fluid overload in liver disease, heart failure and ...

The sponsor submitted a new cost analysis based on a decision tree model with an embedded Markov model. This model evaluated the costs per patient and system impact of the PeritX peritoneal catheter ...